BrightGene Bio Stock Forecast - Daily Balance Of Power
| 688166 Stock | 30.14 1.06 3.40% |
BrightGene Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BrightGene Bio stock prices and determine the direction of BrightGene Bio Medical's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of BrightGene Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
BrightGene |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.7215 | 0.7067 |
| Check BrightGene Bio Volatility | Backtest BrightGene Bio | Trend Details |
BrightGene Bio Trading Date Momentum
| On September 30 2024 BrightGene Bio Medical was traded for 34.50 at the closing time. The highest price during the trading period was 35.05 and the lowest recorded bid was listed for 30.36 . The volume for the day was 22.8 M. This history from September 30, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 16.48% . The overall trading delta to the current price is 39.74% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare BrightGene Bio to competition
BrightGene Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BrightGene Bio stock to make a market-neutral strategy. Peer analysis of BrightGene Bio could also be used in its relative valuation, which is a method of valuing BrightGene Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BrightGene Bio Market Strength Events
Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns.
| Accumulation Distribution | 255668.0 | |||
| Daily Balance Of Power | (0.88) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 30.64 | |||
| Day Typical Price | 30.47 | |||
| Price Action Indicator | (1.03) | |||
| Period Momentum Indicator | (1.06) | |||
| Relative Strength Index | 43.97 |
BrightGene Bio Risk Indicators
The analysis of BrightGene Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BrightGene Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting brightgene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.35 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in BrightGene Stock
BrightGene Bio financial ratios help investors to determine whether BrightGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BrightGene with respect to the benefits of owning BrightGene Bio security.